Cargando…
Retracted: Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567431/ https://www.ncbi.nlm.nih.gov/pubmed/37829626 http://dx.doi.org/10.1155/2023/9840736 |
| _version_ | 1785119126422814720 |
|---|---|
| author | and Alternative Medicine, Evidence-Based Complementary |
| author_facet | and Alternative Medicine, Evidence-Based Complementary |
| author_sort | and Alternative Medicine, Evidence-Based Complementary |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10567431 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105674312023-10-12 Retracted: Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-10-04 /pmc/articles/PMC10567431/ /pubmed/37829626 http://dx.doi.org/10.1155/2023/9840736 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction and Alternative Medicine, Evidence-Based Complementary Retracted: Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia |
| title | Retracted: Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia |
| title_full | Retracted: Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia |
| title_fullStr | Retracted: Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia |
| title_full_unstemmed | Retracted: Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia |
| title_short | Retracted: Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia |
| title_sort | retracted: analysis of the clinical efficacy of azacytidine + venetoclax in the treatment of elderly patients with relapsed refractory acute myeloid leukemia |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567431/ https://www.ncbi.nlm.nih.gov/pubmed/37829626 http://dx.doi.org/10.1155/2023/9840736 |
| work_keys_str_mv | AT andalternativemedicineevidencebasedcomplementary retractedanalysisoftheclinicalefficacyofazacytidinevenetoclaxinthetreatmentofelderlypatientswithrelapsedrefractoryacutemyeloidleukemia |